Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
SPDR Series Trust - SPDR S&P Biotech ETF
XBI
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests...
substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (ARCA:XBI)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(124)
•••
inviolablspirit
X
Post by
inviolablspirit
on Apr 08, 2025 10:32am
CEO Nick Kadysh - Pharmala Biotech Interview
For investors interested in the psychedelics sector of biotech. Pharmala Biotech the #1 supplier of GMP MDMA for clinical trials worldwide. The company is a supplier of MDMA for commercial
...more
(0)
•••
GwenTracy
X
Post by
GwenTracy
on Apr 13, 2023 4:02am
Kevin Harrington Discusses FSD Pharma
I believe this new product will aid society in reducing the
...more
(0)
•••
GwenTracy
X
Post by
GwenTracy
on Jul 15, 2022 9:37pm
FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent
(0)
•••
GwenTracy
X
Post by
GwenTracy
on Jun 03, 2022 5:21am
FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance
(0)
•••
GwenTracy
X
Post by
GwenTracy
on Jun 02, 2022 12:31am
FSD Pharma Files Investigational New Drug Application “IND”
(0)
•••
GwenTracy
X
Post by
GwenTracy
on May 11, 2022 1:43am
FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets
(0)
•••
GwenTracy
X
Post by
GwenTracy
on Apr 30, 2022 11:43pm
FSD Pharma Inc: Lucid MS Video
(0)
•••
GwenTracy
X
Post by
GwenTracy
on Apr 23, 2022 2:39am
"Julia Levy Award" Recipient David Allan and Dr. John McGraw
(0)
•••
GwenTracy
X
Post by
GwenTracy
on Apr 16, 2022 11:15am
FSD Pharma Inc: Lucid MS Video
FSD Pharma is delighted to announce pre-clinical findings
...more
(0)
•••
GwenTracy
X
Post by
GwenTracy
on Apr 09, 2022 12:27pm
FSD: Cancellation of Certain Shares Issued to Former CEO
FSD Pharma Announces Cancellation of Certain Shares Issued to Former Chief Executive Officer Dr. Raza Bokhari TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A)
...more
(0)
•••
GwenTracy
X
Post by
GwenTracy
on Apr 07, 2022 12:38pm
FSD Pharma Issues Corporate Updates
FSD Pharma Issues Corporate Updates TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to
...more
(0)
•••
GwenTracy
X
Post by
GwenTracy
on Apr 06, 2022 1:59am
iMining: First Hospital Foundation in Decentraland Metaverse
iMining Enters into Agreement for the First-Ever Hospital Foundation to Be Launched in the Decentraland Metaverse Vancouver, British Columbia--(Newsfile Corp.) - iMining Technologies Inc
...more
(0)
•••
GwenTracy
X
Post by
GwenTracy
on Feb 19, 2022 1:56am
FSD Pharma; Recapping 2021 and What to Look Forward in 2022
(0)
•••
GwenTracy
X
Post by
GwenTracy
on Feb 04, 2022 11:00am
FSD Pharma Inc: Lucid MS Video
FSD Pharma is pleased to share pre-clinical data demonstrating the effectiveness of its lead drug candidate, Lucid-MS, in treating Multiple Sclerosis. The unique potential therapeutic value of Lucid
...more
(0)
•••
GwenTracy
X
Post by
GwenTracy
on Jan 01, 2022 1:04am
FSD Pharma Announces Share Repurchase Program
FSD Pharma Announces Share Repurchase Program TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding
...more
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
CONTENT CREATORS: Learn How to Become a Stockhouse Contributor